Out Of Pocket Expenditure - page 103

• Forecast: Inpatient Long-Term Care Expenditure by Financing Scheme and Type of Provider in Poland

  • Million US Dollars PPP
  • 2024 to 2028
  • ReportLinker Research
• Forecast: Home-Based Long-Term Care Expenditure (Health) by Financing Scheme and Type of Provider in Lithuania

  • Million Euros
  • 2024 to 2028
  • ReportLinker Research
• Forecast: Home-Based Long-Term Care Expenditure (Health) by Financing Scheme and Type of Provider in Lithuania

  • Million Euros
  • 2024 to 2028
  • ReportLinker Research
• Forecast: General Outpatient Curative Care Expenditure by Financing Scheme and Type of Provider in Luxembourg

  • Percent of Total Current Health Expenditure
  • 2024 to 2028
  • ReportLinker Research
• Forecast: Home-Based Long-Term Care Expenditure (Health) by Financing Scheme and Type of Provider in Latvia

  • Euros Per Capita, Constant=2015
  • 2024 to 2028
  • ReportLinker Research
• Forecast: Home-Based Long-Term Care Expenditure (Health) by Financing Scheme and Type of Provider in Latvia

  • Euros Per Capita, Constant=2015
  • 2024 to 2028
  • ReportLinker Research
• Forecast: Dental Outpatient Curative Care Expenditure by Financing Scheme and Type of Provider in Australia

  • US Dollars PPP Per Capita
  • 2024 to 2028
  • ReportLinker Research
• Forecast: Dental Outpatient Curative Care Expenditure by Financing Scheme and Type of Provider in Australia

  • US Dollars PPP Per Capita
  • 2024 to 2028
  • ReportLinker Research
• Forecast: Home-Based Curative and Rehabilitative Care Expenditure by Financing Scheme and Type of Provider in the Netherlands

  • US Dollars Per Capita, PPP=2015
  • 2024 to 2028
  • ReportLinker Research
• Forecast: Home-Based Curative and Rehabilitative Care Expenditure by Financing Scheme and Type of Provider in the Netherlands

  • US Dollars Per Capita, PPP=2015
  • 2024 to 2028
  • ReportLinker Research
• Forecast: Long Term Care Expenditure by Financing Scheme and Type of Provider in Portugal

  • US Dollars PPP Per Capita
  • 2024 to 2028
  • ReportLinker Research
• Forecast: Pharmaceuticals and Other Medical Non-Durable Goods Expenditure by Financing Scheme and Type of Provider in Portugal

  • Million Euros
  • 2024 to 2028
  • ReportLinker Research
• Forecast: Outpatient Rehabilitative Care Expenditure by Financing Scheme and Type of Provider in Lithuania

  • Percent of Financing Scheme
  • 2024 to 2028
  • ReportLinker Research
• Forecast: Outpatient Rehabilitative Care Expenditure by Financing Scheme and Type of Provider in Lithuania

  • Percent of Financing Scheme
  • 2024 to 2028
  • ReportLinker Research
• Forecast: Day Long-term Care Expenditure (Health) by Financing Scheme and Type of Provider in Hungary

  • US Dollars Per Capita, PPP=2015
  • 2024 to 2028
  • ReportLinker Research
• Forecast: Day Long-term Care Expenditure (Health) by Financing Scheme and Type of Provider in Hungary

  • US Dollars Per Capita, PPP=2015
  • 2024 to 2028
  • ReportLinker Research
• Forecast: Over-the-Counter Medicines Expenditure by Financing Scheme and Type of Provider in Estonia

  • Percent of Total Current Health Expenditure
  • 2024 to 2028
  • ReportLinker Research
• Forecast: Long-Term Care Expenditure (Health) by Financing Scheme and Type of Provider in Japan

  • Percent of Total Current Health Expenditure
  • 2024 to 2028
  • ReportLinker Research
• Forecast: Long-Term Care Expenditure (Health) by Financing Scheme and Type of Provider in Japan

  • Percent of Total Current Health Expenditure
  • 2024 to 2028
  • ReportLinker Research
• Forecast: Curative and Rehabilitative Care Expenditure by Financing Scheme and Type of Provider in Switzerland

  • Percent of Total Current Health Expenditure
  • 2024 to 2028
  • ReportLinker Research
• Forecast: Curative and Rehabilitative Care Expenditure by Financing Scheme and Type of Provider in Switzerland

  • Percent of Total Current Health Expenditure
  • 2024 to 2028
  • ReportLinker Research
• Forecast: Over-the-Counter Medicines Expenditure by Financing Scheme and Type of Provider in Poland

  • US Dollars Per Capita, PPP=2015
  • 2024 to 2028
  • ReportLinker Research
• Forecast: Long-Term Care Expenditure (Health) by Financing Scheme and Type of Provider in Belgium

  • Percent of Function
  • 2024 to 2028
  • ReportLinker Research
• Forecast: Pharmaceuticals and Other Medical Non-Durable Goods Expenditure by Financing Scheme and Type of Provider in Japan

  • Percent of Function
  • 2024 to 2028
  • ReportLinker Research
• Forecast: Pharmaceuticals and Other Medical Non-Durable Goods Expenditure by Financing Scheme and Type of Provider in Japan

  • Percent of Function
  • 2024 to 2028
  • ReportLinker Research
• Forecast: Over-the-Counter Medicines Expenditure by Financing Scheme and Type of Provider in Belgium

  • Percent of Financing Scheme
  • 2024 to 2028
  • ReportLinker Research
• Forecast: Basic Health Care Services and Pharmaceuticals Expenditure by Financing Scheme and Type of Provider in Mexico

  • US Dollars PPP Per Capita
  • 2024 to 2028
  • ReportLinker Research
• Forecast: Basic Health Care Services and Pharmaceuticals Expenditure by Financing Scheme and Type of Provider in Mexico

  • US Dollars PPP Per Capita
  • 2024 to 2028
  • ReportLinker Research
• Forecast: Total Pharmaceutical Expenditure by Financing Scheme and Type of Provider in Australia

  • US Dollars Per Capita, PPP=2015
  • 2024 to 2028
  • ReportLinker Research
• Forecast: Total Pharmaceutical Expenditure by Financing Scheme and Type of Provider in Australia

  • US Dollars Per Capita, PPP=2015
  • 2024 to 2028
  • ReportLinker Research

• «
• 101
• 102
• 103
• 104
• 105
• »